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including 42.9% genotype 1, 14.3% genotype 2, 19.0%
genotype 3 and 23.8% genotype 6. Genotype 1 was
predominant in Beijing, while genotype 6 was mainly
detected in Guangdong. The levels of IFN-g production
and antibody reactivity from chronic infection donors were
signiﬁcantly higher than those from recovery and false
positive infection donors (p < 0.001), but no statistical
difference of IFN-a among populations from three HCV
infection statuses was observed.
Conclusion: IFN-g but IFN-a may play a role paralleled with
antibody in viral clearance during natural history of HCV
infection.
PP-149 Seroprevalence of anti-HCV in children living in
Ulaanbaatar, Mongolia
D. Tungalag1 *, D. Davaasuren1, B. Baigal1, Y. Dahgwahdorj1.
1Health Science University of Mongolia, Mongolia
Background: Our previous study established that HCV
infection is wide-spread in Mongolia. So, many Government
and non-Government measures on HCV prevention are non-
speciﬁc. So, there is needed to check the results of the
measures.
Objective: To assess prevalence of HCV infection in
Mongolian children.
Methods: We randomly selected 199 “healthy” children
(ages 1 15) in May 2009, from Ulaanbaatar, matched by age
and sex and tested serum of all subjects for anti-HCV.
Results: Eighteen of 193 serum samples tested positive
for anti-HCV (9.3%). Older age was more likely to show a
positive test (presented in the table by age and sex).
Table 1. Anti HCV test results by age and number of subjects
Age Subjects Anti-HCV %
n male n male
1 21 12 0 0
3 24 14 0 0
5 28 14 3 2 10.7
7 26 12 0 0
9 26 13 4 3 15.4
11 23 12 3 2 13.0
13 23 10 3 1 13.0
15 22 12 5 2 22.7
Total 193 99 18 10 9.3
Discussion and Conclusion: More half the population of
Mongolia lives in Ulaanbaatar. We have carried two
studies on the prevalence of HCV infection in children in
Ulaanbaatar (1998, 2002). These studies did not showed
a signiﬁcant difference in HCV seroprevalcne between
rural and urban subjects. As the results, we estimate the
prevalence of HCV infection in Ulaanbaatar to the ﬁgure
for the whole Mongolian population. The seroprevalence,
found in this study is signiﬁcantly higher compared with our
previous study. Therefore, all measures to help prevent HCV
infection in Mongolia should be intensiﬁed.
PP-150 Evaluation of serum TIMP-1 & TGF-b1 in
Egyptian patients with chronic hepatitis C,
genotype 4 & chronic hepatitis B infection
H. El Garem1 *, G. El deen Esmat1, O. Shaker1,
M. Mohaned1, A. Salama1, A. Abolfotoh1. 1Cairo University,
Egypt
Background: HCV & HBV infections are known to be
major public health problem in Egypt. As chronic liver
disease progresses, an imbalance occurs between synthesis
and breakdown of extra cellular matrix (ECM). Matrix
metallproteinases (MMPs) are involved in degrading ECM
while tissue inhibitors of metalloproteinases (TIMPs) prevent
their ﬁbrolytic action. Transforming growth factor b1
(TGF-b1) is a key mediator of liver ﬁbrogenesis. Aim of this
study is evaluating TIMPs & TGF-b1 as ﬁbrogenic seromarkers
in comparison to histopathological examination of liver.
Methods: Commercially available ELISA assays were used
to study circulating levels of TIMP-1 & TGF-b1 in 50
patients with chronic hepatitis C patients and 20 patients
with chronic hepatitis B compared to 10 healthy control
subjects.
Results: In HCV patients, TIMP-1 was elevated with more
progresive liver disease with a sensitivity of 100% the
speciﬁcity of 87%. Serum level of TIMP-1 in chronic
hepatitis (B) was slightly decreased from healthy control
without signiﬁcant correlation. Its mean and standard
deviation was (157.81±44.1) and (164.18±42.22) in the
HBV and control group respectively.
In comparison between HCV & HBV patients there was
signiﬁcant increase in serum level of TIMP-1 in HCV patients
than HBV patients.
Serum levels of TGF-b1 were decreased in HCV patients
signiﬁcantly from healthy control group (mean 138.27±47.8)
to F4 patients (mean 46.97±23.49). Serum levels of
TGF-b1 in chronic hepatitis B patients showed no statistical
difference from the healthy control. Its mean and standard
deviation in HBV group and control group were (114.9±53.11
and 138.37±47.86) respectively.
Conclusion: TIMP-1 is a reliable predictor to detect
advanced ﬁbrosis, in HCV patients genotype 4.
PP-151 Increased PD-L1 expression and PD-L1/CD86
ratio on dendritic cells were inversely
associated with impaired dendritic cells
function in HCV chronic infection
T. Shen1 *, X.M. Chen1, Q. Xu1, S. Liu2, F.M. Lu1.
1Department of Microbiology, Peking University Health
Science Center, Beijing 100191, China, 2Artiﬁcial Liver
Center, Beijing You’an Hospital, Afﬁliated to Capital
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Hepatitis C virus (HCV)-speciﬁc T cell immunity was impaired
in HCV chronic infection and resulted in the persistence
of HCV infection. Dysfunction of dendritic cells (DCs) was
believed to be involved in this T cell exhaustion, but the
mechanisms were rarely understood.
In this study, we evaluated surface costimulatory marker
(CD83, CD86, and CD40) and coinhibitory marker (PD-L1)
expression and allostimulatory capacity of plasmacytoid
DCs and myeloid DCs in twenty ﬁve HCV-infected patients
compared to twenty healthy controls. All patients and
control were seronegative for anti-HIV and anti-HBV. DCs
were isolated from PBMC by use of BDCA-1 positive
cell isolation kit for myeloid DCs and BDCA-4 positive
cell isolation kit for plasmacytoid DCs according to the
manufacturer’s instructions.
We found both costimulatory marker and coinhibitory
marker expression were increased in HCV infection
compared with healthy control. The ratio of PD-L1 versus
CD86 was also increased in HCV-infected patients and
the ratio positive correlated with PD-L1 expression on
DCs. Allostimulatory capacity of DCs was impaired in HCV
infection and this allogeneic MLR was inversely correlated
with PD-L1 expression and PD-L1/CD86 ratio.
These ﬁndings suggested that the effect of inhibitory marker
PD-L1 overwhelmed the effect of costimulatory markers
and negatively regulated DC-T activation. Our ﬁnding will
be helpful to understand the mechanism of dysfunction
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of DCs in HCV infection and shed light on the DC-based
immunotherapeutic strategy.
PP-152 A novel model predicting mortality of the
hospitalized patients with acute-on-chronic
hepatitis B liver failure
M.-H. Zheng1 *, K.-Q. Shi1, Y.-C. Fan2, H. Li3, C. Ye1,
D.-Q. Sun4, L.-F. Li4, Y.-P. Chen1. 1Department of
Infection and Liver Diseases, Liver Research Center, the
First Afﬁliated Hospital of Wenzhou Medical College,
2Department of Hepatology, Qilu Hospital of Shandong
University, 3Intensive Care Unit, Tianjin Infectious Disease
Hospital, 4School of the First Clinical Medical Sciences,
Wenzhou Medical College, China
Background: Liver failure usually progresses into a poor
mortality. Despite their accuracy, classic models including
model for end-stage liver disease (MELD) and Child Pugh
score (CPS), are mainly being accepted to determine the
prognosis of patients with end-stage liver disease, However,
these models are still controversial in predicting mortality
of patients with acute-on-chronic hepatitis B liver failure
(ACHBLF). In this study, we aim to evaluate the possibility
to better predict mortality of the hospitalized patients with
ACHBLF using a novel logistic regression model (LRM).
Methods: The LRM was constructed using data from 242
consecutive patients with ACHBLF at Liver Research Center,
Wenzhou, China (internal cohort). The LRM was tested
on 210 patients listed for medical treatment at Tianjin
Infectious Disease Hospital, China (external cohort). The
receiver operating characteristic curves (ROCs) were drawn
for LRM, MELD, CPS and Sun’s model. Predictions of
mortality obtained with four models on the same datasets
were compared using areas under ROC curves (AUC).
Result: In internal cohort, there were 75 patients who died
in hospital (31.0%). The mean MELD score for the patients
who died was signiﬁcantly greater than those who survived
(26.8 vs. 22.4, p < 0.001). The LRM performed excellent
diagnostic accuracy signiﬁcantly better than MELD, CPS and
Sun’s model both in the internal cohort (AUC = 0.873 vs.
0.694 vs. 0.718 vs. 0.786; p < 0.001, p < 0.001, p = 0.002,
respectively) and in the external cohort (AUC = 0.844 vs.
0.775 vs. 0.601 vs. 0.753; p = 0.035, p < 0.001, p = 0.004,
respectively).
Conclusion: Our newly established LRM was superior to
MELD, CPS and Sun’s model in predicting mortality risk of
hospitalized patients with ACHBLF.
PP-153 Acute fatty liver of pregnancy: report of
27 cases
H.F. Xiong1 *, J.D. Jia2,3, L.M. Guo1, J.Y. Liu1, Y.Q. Jiao1,
Q.H. Dong1, Y. Wang1. 1Beijing Ditan Hospital, 2Beijing
Friendship Hospital, 3Capital Medical University, China
Objective: To explore the clinical proﬁle, biochemical
ﬁndings, complications and maternal outcome in patients
of acute fatty liver of pregnancy (AFLP).
Methods: Patients with AFLP hospitalized in Beijing Ditan
Hospital from Sep 1996 to Nov 2010 were analyzed. The
clinical feature, laboratory examination, and treatment
were retrospectively analyzed.
Results: There were 27 women included in this study with
a mean age of 27.7±3.3 years (23 to 34 years). The
mean gestational age was 35.9±2.2 weeks. There were
3 cases death (11.1%). The most common symptoms at
admission were jaundice (20 cases), fatigue (16 cases),
nausea and vomiting (13 cases) and pruritus (5 cases).
During hospital stay, three patients presented psychiatric
symptom, manifesting as visual hallucination, auditory
hallucination, and delusion of persecution. Laboratory
examination: WBC increased, anemia, thrombocytopenia,
hypoalbuminemia, the total bile acid increased, coagulation
dysfunction (PTA< 80%) and renal injury. Compared with
non-ALF group (n = 14), the ALF group (n = 13) patients have
higher white blood cell, TBIL, DBIL, Cr lever and lower
hemoglobin and PTA (P< 0.01). The ALF group patients were
more likely to present hypoglycemia, acute renal failure,
coagulation disorders, acute respiratory distress syndrome,
neonatal asphyxia, post-partum hemorrhage and fetal death
(P< 0.05). There are 24 cases discharged home with full
recovery of hepatic and renal function. Other three cases
were dead. The causes of death were cerebral hemorrhage,
post-partum hemorrhage, hemorrhagic shock and multiple
organ failure.
Conclusions: (1) Patients with ALF are more likely to occur
multiple organ dysfunction, asphyxia neonatorum and fetal
death. (2) With adequate support, the most patients may
have full recovery of hepatic and renal function.
PP-154 Alpha fetoprotein is a novel inhibitor of
apoptosis protein mediated human hepatoma
Bel 7402 cells resisting the apoptosis induced
by TRAIL
M.S. Li1 *, M.Y. Zhu1, X.J. Xie2. 1Key Laboratory of
Molecular Biology, Hainan Medical College, Haikou 571101,
Hainan Province, China, 2Department of Pathophysiology,
Hainan Medical College, Haikou 571101, Hainan Province,
China
Objective: AFP has a property to maintain hepatocellular
carcinoma cells (HCC) growth in vivo, and hepatitis B
virus X (HBX) protein up-regulates AFP expression in HCC,
but the critical function of AFP was unclear, the present
investigation explore the inﬂuence of AFP on the apoptosis
induced by tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL) of HCC.
Methods: Co-localization and interactIon of AFP and
caspase-3 or caspase-8 observed by confocal microscopy
or co-immunoprecipitation (Co-IP); siRNA was applied to
knockdown the expression of AFP in Bel 7402 cells (AFP-
producing); The activity of caspase-3 or caspase-8 was
detected by protease activity colorimetric methods; Flow
cytometry and MTT were used to analyze apoptosis and
growth of the cells; and ﬂuorescent microscopy was used to
observe the apoptosis of Bel 7402 cells.
Results: AFP harbors a function to interact with caspase-3
in cytoplasm, but could not binding with caspase-8; The
activity of caspase-3 or caspase-8 was enhanced and the
expression of AFP was repressed when treated with all trans
retinoic acid (40mmol/L) plus TRAIL (2nmol/L); Treated
with TRAIL (2nmol/L) alone, the activity of caspase-8 was
promoted and activity of caspase-3 has not any alteration;
AFP was able to inhibit the activity of caspase-3 but it has
any effect on the activity of caspase-8 in vitro; Bel 7402 cells
resisted the apoptosis induced by TRAIL (2nmol/L); While
knockdown AFP expression by siRNA followed treatment
with TRAIL (2nmol/L), caspase-3 activity was increased but
caspase-8 activity had not any change, and Bel 7402 cells
growth were inhibited (ratio 48.4%), and TRAIL could induce
the apoptosis of the cancer cells.
Conclusions: AFP inhibits caspase-3 activity is the pivotal
events that AFP mediated HCC resists apoptosis induced
by TRAIL.
